Order Amending Schedule VI to the Controlled Drugs and Substances Act (Novel Fentanyl Precursors): SOR/2023-103

Canada Gazette, Part II, Volume 157, Number 12

Registration
SOR/2023-103 May 19, 2023

CONTROLLED DRUGS AND SUBSTANCES ACT

P.C. 2023-454 May 18, 2023

Her Excellency the Governor General in Council, on the recommendation of the Minister of Mental Health and Addictions and Associate Minister of Health, considering that it is necessary in the public interest, makes the annexed Order Amending Schedule VI to the Controlled Drugs and Substances Act (Novel Fentanyl Precursors) under section 60^{footnote a} of the Controlled Drugs and Substances Act ^{footnote b}.

Order Amending Schedule VI to the Controlled Drugs and Substances Act (Novel Fentanyl Precursors)

Amendment

1 Item 30 of Part 1 of Schedule VI to the Controlled Drugs and Substances Act ^{footnote b} is replaced by the following:

• 30 N-Phenyl-4-piperidinamine (N-phenylpiperidin-4-amine), its salts, derivatives and analogues and salts of derivatives and analogues, including:
  • (1) 4-anilino-1-boc-piperidine (tert-butyl 4-(phenylamino)piperidine-1-carboxylate)
  • (2) 4-fluoro anilino-1-boc-piperidine (tert-butyl 4-((4-fluorophenyl)amino)piperidine-1-carboxylate)
  • (3) N-(4-fluorophenyl)-4-piperidinamine (N-(4-fluorophenyl)piperidin-4-amine)
  • (4) 4-bromo anilino-1-boc-piperidine (tert-butyl 4-((4-bromophenyl)amino)piperidine-1-carboxylate)

Coming into Force

2 This Order comes into force on August 30, 2023.

N.B. The Regulatory Impact Analysis Statement for this Order appears following SOR/2023-102, Regulations Amending the Precursor Control Regulations (Novel Fentanyl Precursors).